Lenses linked to increased inflammatory markers

Article

Tear levels of inflammatory markers increase in patients who wear corneal refractive therapy lenses, compared to those who wore silicone-hydrogel lenses or no lenses.

Tear levels of inflammatory markers increase in patients who wear corneal refractive therapy lenses, compared to those who wore silicone-hydrogel lenses or no lenses.

A team led by Dr Javier González-Pérez, Ocular Surface and Contact Lens Research Laboratory, Faculty of Optics and Optometry, University of Santiago de Compostela, Spain, compared 60 participants in a prospective, case-controlled study.

Of the subjects studied, 28 wore a silicone-hydrogel lens continuously for 30 nights and 32 wore a corneal refractive therapy lens on an overnight basis. There were also 32 control subjects included in the investigation.

Twelve months after initial lens fitting tear samples were obtained and assayed using ELISA cytokines IL-6 andIL-8, matrix metalloproteinase 9 (MMP-9) and epidermal growth factor (EGF).

EGF significantly rose after 12 months for both lenses and IL-6, IL-8 and MMP-9 only increased after corneal refractive therapy. Inflammatory response for corneal refractive therapy patients was linked to the degree of myopia and the presence of corneal staining.

An increased level of MMP-9 and EGF was associated with the presence of corneal-pigmented arch in those who wore corneal refractive therapy lenses.,/p>

The abstract was recently published in the British Journal of Ophthalmology.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.